Conference summary

Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and Population Approach Group of Australia and New Zealand


Shared horizons: Optimising drug response to improve patient outcomes

25–29 November 2019

Rydges Lakeland Resort, Queenstown, New Zealand

Number of delegates

Lead time
1 year

Number of speakers
126 oral presenters
128 poster presenters

Number of sponsors
30 sponsors and exhibitors

Number of abstract submissions

Meet the conference management team

Lidia Dalton

Founder and Managing Director

Leanne Mulheran

Event Manager

Sarah Hargreaves

Program and Association Coordinator

Lisa Bentley

Finance Administrator

Like this conference profile? Share the love...

ASCEPT-PAGANZ 2019 Joint Scientific Meeting

Expert Events managed the ASCEPT- PAGANZ 2019 Joint Scientific Meeting that was held at Rydges Lakeland Resort, Queenstown, New Zealand.

ASCEPT is the professional and independent society in Australia and New Zealand for those with expertise in the use and toxicity of medicines and chemicals. ASCEPT is a member-based organisation and membership comprises clinicians, pharmacologists, pharmacists and scientists. Established in 1966, ASCEPT is affiliated with the International Union of Basic and Clinical Pharmacology (IUPHAR) and the International Union of Toxicology (IUTOX). ASCEPT has hosted International Congresses of Pharmacology (in 1987 and 2004) and Toxicology (in 2001 and 2004), and the South East Asian Western Pacific Regional Meeting of Pharmacologists (SEAWP-RMP) in 2007.

The Population Approach Group of Australia & New Zealand (PAGANZ) is an incorporated society founded on an interest in pharmacology and therapeutic applications using the population approach. Since 1999, an annual PAGANZ scientific meeting has been held in the Southern hemisphere, to encourage the use and development of pharmacometrics primarily in Australia and New Zealand.

A key focus of this meeting is the application of population modelling and simulation techniques in the experimental, clinical and regulatory settings of clinical drug development. PAGANZ is proud to be a world leader in teaching and support of research in this important area of pharmacology and drug development.